John A. Johnson, MD, MBA: The microvascular complications of diabetes include anything from effects on [a patient’s] blood pressure, peripheral neuropathy, the ability to have abnormalities in their sensation (in their hands and feet), and blindness. Macrovascular complications include cardiovascular effects such as heart attacks, stroke, and end-stage kidney disease.
So we look at ways that we can, in a preventative approach, reduce those complications because, as we’ve seen at WellCare, in patients who don’t have access to care—either inadequate access or lack of behavioral modification in lifestyle changes—a negative impact in their outcomes is seen.
We work with the provider community to make them aware of the members that they have within their care—that are WellCare members—and [figure out] how we can partner with them and equip them with tools to enhance the care of diabetics to prevent or delay the onset of these micro- and macrovascular complications.
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
2 Commerce Drive
Cranbury, NJ 08512